Accès à distance ? S'identifier sur le proxy UCLouvain
Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT).
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2013 |
Language | Anglais |
Journal information | "European Journal of Clinical Pharmacology" - Vol. 69, no. 3, p. 605-616 (2013) |
Peer reviewed | yes |
Publisher | Springer ((Germany) Heidelberg) |
issn | 0031-6970 |
e-issn | 1432-1041 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie UCL - (SLuc) Service d'hépato-gastro-entérologie |
Links |
- Van Steenbergen Werner, Peeters Pascal, De Bondt Joris, Staessen Dirk, Büscher Henri, Laporta Thiery, Roskams Tania, Desmet Valeer, Nimesulide-induced acute hepatitis: evidence from six cases, 10.1016/s0168-8278(98)80188-8
- McCormick PA, Kennedy F, Curry M, Traynor O, COX 2 inhibitor and fulminant hepatic failure, 10.1016/s0140-6736(05)74867-4
- Schattner A., Sokolovskaya N., Cohen J., Fatal hepatitis and renal failure during treatment with nimesulide, 10.1046/j.1365-2796.2000.00612.x
- Weiss P, Mouallem M, Bruck R, Hassin D, Tanay A, Brickman CM, Farfel Z, Bar-Meir S (1999) Nimesulide-induced hepatitis and acute liver failure. Isr Med Assoc J 1:89–91
- Andrade Raúl J., Lucena M.Isabel, Fernández M.Carmen, González Mercedes, Letters to the Editor, 10.1016/s0168-8278(00)80208-1
- Macia MA, Carvajal A, del Pozo JG, Vera E, del Pino A (2002) Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance System. Clin Pharmacol Ther 72:596–597
- Merlani Giorgio, Fox Mark, Oehen Hans-Peter, Cathomas Gieri, Renner Eberhard L., Fattinger Karin, Schneemann Markus, Kullak-Ublick Gerd A., Fatal hepatotoxicity secondary to nimesulide, 10.1007/s002280100312
- (2007) Nimesulide withdrawal too little, too late? Irish Pharmacy J85
- Finish Medicines Agency (2002) The sale of Nimed, an anti-inflammatory analgesic, is temporarily suspended due to its adverse liver effects. Available at: http://www.fimea.fi/whats_new/1/0/the_sale_of_nimed_an_anti-inflammatory_analgesic_is_temporarily_suspended_due_to_its_adverse_liver_effects
- Irish Medicines Board (IMB) (2007) IMB announces immediate suspension of the marketing of medicines containing nimesulide. IRB, Dublin
- World Health Organization (WHO) (2007). Oral nimesulide: marketing suspended in Ireland due to reports of liver failure. WHO Information Exchange System Alert No 113 (23 May 2007). WHO, Geneva
- European Medicines Agency (EMEA) (2004) Committee for proprietary medicinal products opinion following an article 31 referral. Nimesulide-containing products. EMEA Press Office, London
- European Medicines Agency (EMEA) (2007) European Medicines Agency recommends restricted use of nimesulide-containing medicinal products. EMEA Press Office, London
- European Medicines Agency (EMEA) (2007) Questions and answers on the CHMP recommendation on nimesulide-containing medicines. EMEA Agency Press Office, London
- Lapeyre-Mestre Maryse, de Castro Ana Maria Rueda, Bareille Marie-Pierre, Pozo Javier Garcia del, Requejo Ana Alvarez, Arias Louis Martin, Montastruc Jean-Louis, Carvajal Alfonso, Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems, 10.1111/j.1472-8206.2006.00416.x
- Lee Chang-Hsing, Wang Jung-Der, Chen Pau-Chung, Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs, 10.1002/pds.1966
- Traversa G., Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs, 10.1136/bmj.327.7405.18
- Théophile Hélène, Laporte Joan-Ramon, Moore Nicholas, Martin Karin-Latry, Bégaud Bernard, The Case-Population Study Design : An Analysis of its Application in Pharmacovigilance, 10.2165/11592140-000000000-00000
- Benichou Christian, Danan Gaby, Flahault Antoine, Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge, 10.1016/0895-4356(93)90102-7
- Danan Gaby, Benichou Christian, Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries, 10.1016/0895-4356(93)90101-6
- Edwards I. Ralph, Biriell Cecilia, Harmonisation in Pharmacovigilance : , 10.2165/00002018-199410020-00001
- Macedo A. F., Marques F. B., Ribeiro C. F., Teixeira F., Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability, 10.1046/j.1365-2710.2003.00475.x
- Meyboom Ronald H.B., Hekster Yechiel A., Egberts Antoine C.G., Gribnau Frank W.J., Edwards I. Ralph, Causal or Casual? : The Role of Causality Assessment in Pharmacovigilance, 10.2165/00002018-199717060-00004
- Methodology W.C.C.f.D.S (2010) Guidelines for ATC classification and DDD assignment 2011. WHO Collaborating Centre for Drug Statistics Methodology, Oslo
- Arimone Yannick, Bégaud Bernard, Miremont-Salamé Ghada, Fourrier-Réglat Annie, Molimard Mathieu, Moore Nicholas, Haramburu Françoise, A new method for assessing drug causation provided agreement with experts' judgment, 10.1016/j.jclinepi.2005.08.012
- Arimone Yannick, Bégaud Bernard, Miremont-Salamé Ghada, Fourrier-Réglat Annie, Moore Nicholas, Molimard Mathieu, Haramburu Françoise, Agreement of expert judgment in causality assessment of adverse drug reactions, 10.1007/s00228-004-0869-2
- Arimone Yannick, Miremont-Salamé Ghada, Haramburu Françoise, Molimard Mathieu, Moore Nicholas, Fourrier-Réglat Annie, Bégaud Bernard, Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions, 10.1111/j.1365-2125.2007.02937.x
- Théophile Hélène, Arimone Yannick, Miremont-Salamé Ghada, Moore Nicholas, Fourrier-Réglat Annie, Haramburu Françoise, Bégaud Bernard, Comparison of Three Methods (Consensual Expert Judgement, Algorithmic and Probabilistic Approaches) of Causality Assessment of Adverse Drug Reactions : An Assessment Using Reports Made to a French Pharmacovigilance Centre, 10.2165/11537780-000000000-00000
- Gülmez Sinem Ezgi, Lignot-Maleyran Séverine, de Vries Corinne S., Sturkenboom Miriam, Micon Sophie, Hamoud Fatima, Blin Patrick, Moore Nicholas, Administrative complexities for a European observational study despite directives harmonising requirements : EUROPEAN HARMONISATION, 10.1002/pds.3204
- Sánchez-Fueyo Alberto, Hot-topic debate on tolerance: Immunosuppression withdrawal, 10.1002/lt.22421
- Tsochatzis E., Koskinas J., Manesis E.K., Archimandritis A.J., Liver Transplantation in Greek Patients: Epidemiological Data, Morbidity, and Mortality of 71 Patients from a Single Center With 6 Years of Mean Follow-up, 10.1016/j.transproceed.2006.11.010
- Criteria of drug-induced liver disorders, 10.1016/0168-8278(90)90124-a
- MIMS Publications (July 2007). IMB suspension of marketing of nimesulide containing medicines. IMB Notice Information: Human Medicines
Bibliographic reference | Gulmez, Sinem Ezgi ; Larrey, Dominique ; Pageaux, Georges-Philippe ; Lignot-Maleyran, Séverine ; de Vries, Corinne ; et. al. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT).. In: European Journal of Clinical Pharmacology, Vol. 69, no. 3, p. 605-616 (2013) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/117086 |